Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Disorders | 15 | 2015 | 656 | 2.140 |
Why?
|
Turner Syndrome | 8 | 2022 | 131 | 2.120 |
Why?
|
Diabetes Mellitus, Type 1 | 14 | 2022 | 3375 | 1.550 |
Why?
|
Endocrine System Diseases | 2 | 2023 | 252 | 1.220 |
Why?
|
Diabetic Ketoacidosis | 5 | 2020 | 232 | 1.220 |
Why?
|
Endocrinology | 4 | 2015 | 415 | 1.060 |
Why?
|
Diabetes Mellitus, Type 2 | 17 | 2022 | 11090 | 0.920 |
Why?
|
Endocrine System | 1 | 2023 | 114 | 0.870 |
Why?
|
Hypoglycemia | 5 | 2016 | 813 | 0.820 |
Why?
|
Hunger | 1 | 2021 | 194 | 0.730 |
Why?
|
Ghrelin | 1 | 2021 | 266 | 0.700 |
Why?
|
Insulin | 16 | 2022 | 6651 | 0.660 |
Why?
|
Hyperthyroidism | 4 | 2015 | 286 | 0.610 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2016 | 373 | 0.600 |
Why?
|
Gigantism | 1 | 2016 | 14 | 0.590 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 2015 | 35 | 0.550 |
Why?
|
Insulin-Secreting Cells | 4 | 2020 | 972 | 0.550 |
Why?
|
Dwarfism | 1 | 2016 | 148 | 0.530 |
Why?
|
Technetium | 1 | 2015 | 355 | 0.520 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2014 | 23 | 0.510 |
Why?
|
Growth Hormone | 12 | 2021 | 693 | 0.510 |
Why?
|
Growth | 3 | 2016 | 395 | 0.510 |
Why?
|
Insulin-Like Growth Factor I | 6 | 2011 | 2028 | 0.490 |
Why?
|
Peptide Hormones | 1 | 2014 | 131 | 0.480 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1207 | 0.470 |
Why?
|
Child | 58 | 2023 | 74468 | 0.460 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1185 | 0.460 |
Why?
|
Puberty | 8 | 2013 | 462 | 0.450 |
Why?
|
Brain Edema | 4 | 2008 | 619 | 0.440 |
Why?
|
Insulin Resistance | 7 | 2020 | 3884 | 0.420 |
Why?
|
Genetic Counseling | 1 | 2015 | 578 | 0.410 |
Why?
|
Liver Diseases | 1 | 2019 | 1243 | 0.410 |
Why?
|
Monosaccharide Transport Proteins | 5 | 2005 | 431 | 0.400 |
Why?
|
Child Nutrition Disorders | 1 | 2013 | 174 | 0.400 |
Why?
|
Congenital Hypothyroidism | 1 | 2010 | 51 | 0.390 |
Why?
|
Central Nervous System Cysts | 1 | 2010 | 59 | 0.390 |
Why?
|
Caregivers | 1 | 2022 | 1925 | 0.390 |
Why?
|
Adolescent | 55 | 2022 | 85155 | 0.390 |
Why?
|
Blood Glucose | 18 | 2022 | 6259 | 0.360 |
Why?
|
Obesity | 11 | 2022 | 12248 | 0.350 |
Why?
|
Infertility, Female | 1 | 2015 | 763 | 0.350 |
Why?
|
Anti-Asthmatic Agents | 1 | 2013 | 547 | 0.340 |
Why?
|
Anorexia Nervosa | 3 | 2014 | 1339 | 0.320 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 391 | 0.310 |
Why?
|
Karyotyping | 2 | 2021 | 1266 | 0.290 |
Why?
|
Metformin | 8 | 2020 | 804 | 0.280 |
Why?
|
Puberty, Precocious | 3 | 2012 | 136 | 0.280 |
Why?
|
Humans | 101 | 2023 | 715777 | 0.270 |
Why?
|
Estrogens | 2 | 2010 | 1529 | 0.270 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1990 | 0.270 |
Why?
|
Body Height | 8 | 2015 | 1609 | 0.270 |
Why?
|
Hepatocyte Nuclear Factor 4 | 4 | 2020 | 119 | 0.260 |
Why?
|
Galactokinase | 1 | 2004 | 19 | 0.260 |
Why?
|
Craniopharyngioma | 1 | 2006 | 278 | 0.240 |
Why?
|
Thyroid Function Tests | 4 | 2015 | 288 | 0.240 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1382 | 0.240 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1755 | 0.230 |
Why?
|
Fluid Therapy | 4 | 2020 | 608 | 0.230 |
Why?
|
Hypoglycemic Agents | 6 | 2018 | 2775 | 0.220 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1292 | 0.210 |
Why?
|
Liver | 6 | 2014 | 7594 | 0.210 |
Why?
|
Menstruation Disturbances | 2 | 2018 | 142 | 0.210 |
Why?
|
Fetus | 7 | 1995 | 1853 | 0.210 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2021 | 25 | 0.210 |
Why?
|
Growth and Development | 1 | 2021 | 51 | 0.200 |
Why?
|
Immediate-Early Proteins | 1 | 2004 | 457 | 0.200 |
Why?
|
Child, Preschool | 19 | 2019 | 41198 | 0.200 |
Why?
|
Glucose | 10 | 2021 | 4273 | 0.190 |
Why?
|
Promoter Regions, Genetic | 5 | 2010 | 6009 | 0.190 |
Why?
|
Nafarelin | 5 | 1994 | 27 | 0.190 |
Why?
|
Guideline Adherence | 1 | 2010 | 2322 | 0.180 |
Why?
|
Adenoma | 1 | 2010 | 2119 | 0.180 |
Why?
|
Bariatric Surgery | 1 | 2009 | 893 | 0.180 |
Why?
|
Glucose Tolerance Test | 3 | 2018 | 1154 | 0.180 |
Why?
|
Diabetes Mellitus | 2 | 2014 | 5463 | 0.180 |
Why?
|
Thyroxine | 2 | 2015 | 646 | 0.180 |
Why?
|
Immunization | 1 | 2004 | 1277 | 0.180 |
Why?
|
Fasting | 8 | 2018 | 1594 | 0.180 |
Why?
|
Celiac Disease | 2 | 2005 | 762 | 0.180 |
Why?
|
Obesity, Morbid | 1 | 2009 | 1087 | 0.170 |
Why?
|
Gluconeogenesis | 4 | 1988 | 186 | 0.170 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4272 | 0.170 |
Why?
|
Female | 63 | 2022 | 377204 | 0.170 |
Why?
|
Video Games | 1 | 2020 | 178 | 0.170 |
Why?
|
Liver Function Tests | 1 | 2019 | 534 | 0.170 |
Why?
|
Mosaicism | 1 | 2021 | 447 | 0.160 |
Why?
|
Body Fat Distribution | 1 | 2019 | 244 | 0.160 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 3601 | 0.160 |
Why?
|
Lactates | 6 | 1989 | 404 | 0.160 |
Why?
|
Human Growth Hormone | 2 | 2015 | 701 | 0.160 |
Why?
|
Intestine, Small | 2 | 2005 | 1221 | 0.150 |
Why?
|
Pediatrics | 2 | 2015 | 3552 | 0.150 |
Why?
|
Infant | 11 | 2015 | 34569 | 0.140 |
Why?
|
Subcutaneous Fat | 1 | 2019 | 385 | 0.140 |
Why?
|
Luteinizing Hormone | 4 | 1994 | 870 | 0.140 |
Why?
|
Brain | 2 | 2022 | 25206 | 0.140 |
Why?
|
Follicle Stimulating Hormone | 3 | 1993 | 730 | 0.140 |
Why?
|
Transcription Factors | 4 | 2021 | 11953 | 0.140 |
Why?
|
Infant, Newborn | 9 | 2015 | 24798 | 0.140 |
Why?
|
Testosterone | 6 | 2018 | 2359 | 0.130 |
Why?
|
Puberty, Delayed | 3 | 2012 | 114 | 0.130 |
Why?
|
Circadian Rhythm | 3 | 2005 | 2554 | 0.130 |
Why?
|
Intra-Abdominal Fat | 1 | 2019 | 578 | 0.130 |
Why?
|
Nuclear Proteins | 2 | 2021 | 5947 | 0.130 |
Why?
|
Age Determination by Skeleton | 4 | 2012 | 131 | 0.120 |
Why?
|
Pituitary Hormones | 1 | 2015 | 183 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2003 | 1741 | 0.120 |
Why?
|
Liver Glycogen | 2 | 1992 | 37 | 0.120 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2009 | 3770 | 0.120 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2012 | 24 | 0.120 |
Why?
|
Pregnancy, Animal | 1 | 1993 | 131 | 0.120 |
Why?
|
Adrenarche | 1 | 2012 | 6 | 0.120 |
Why?
|
Triiodothyronine | 1 | 2015 | 494 | 0.120 |
Why?
|
Recombinant Proteins | 3 | 2015 | 6803 | 0.120 |
Why?
|
Genetic Load | 1 | 2012 | 16 | 0.120 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7446 | 0.120 |
Why?
|
Energy Metabolism | 6 | 2010 | 2968 | 0.110 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2361 | 0.110 |
Why?
|
Male | 46 | 2020 | 350324 | 0.110 |
Why?
|
RNA, Messenger | 7 | 2008 | 13213 | 0.110 |
Why?
|
Gonadotropin-Releasing Hormone | 4 | 2012 | 1191 | 0.110 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2012 | 101 | 0.110 |
Why?
|
Receptors, LHRH | 1 | 2012 | 160 | 0.110 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2012 | 243 | 0.110 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 3 | 2010 | 426 | 0.100 |
Why?
|
DNA-Binding Proteins | 3 | 2004 | 9730 | 0.100 |
Why?
|
Pregnancy | 12 | 2022 | 27398 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2442 | 0.100 |
Why?
|
Sheep | 3 | 1993 | 1473 | 0.100 |
Why?
|
Glutamine | 1 | 1993 | 556 | 0.100 |
Why?
|
Estradiol | 3 | 2018 | 1978 | 0.100 |
Why?
|
Membrane Glycoproteins | 2 | 2001 | 3824 | 0.100 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2015 | 458 | 0.100 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2010 | 39 | 0.100 |
Why?
|
Mass Screening | 2 | 2023 | 5209 | 0.100 |
Why?
|
Combined Modality Therapy | 4 | 2020 | 8890 | 0.100 |
Why?
|
Pituitary Gland | 2 | 1989 | 662 | 0.090 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2013 | 333 | 0.090 |
Why?
|
Islets of Langerhans | 2 | 2008 | 1409 | 0.090 |
Why?
|
Prolactinoma | 1 | 2010 | 108 | 0.090 |
Why?
|
Body Composition | 4 | 2009 | 2395 | 0.090 |
Why?
|
Fetal Diseases | 1 | 2015 | 900 | 0.090 |
Why?
|
Maternal-Fetal Exchange | 4 | 1993 | 455 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2010 | 12305 | 0.090 |
Why?
|
Body Mass Index | 7 | 2020 | 12535 | 0.090 |
Why?
|
Response Elements | 1 | 2010 | 317 | 0.090 |
Why?
|
Hypogonadism | 4 | 2012 | 769 | 0.090 |
Why?
|
Thiazolidinediones | 2 | 2018 | 484 | 0.090 |
Why?
|
Gonadotropins | 1 | 1989 | 237 | 0.090 |
Why?
|
Pregnancy in Diabetics | 1 | 2010 | 188 | 0.090 |
Why?
|
Fetal Growth Retardation | 2 | 1986 | 556 | 0.080 |
Why?
|
Nutrition Disorders | 1 | 2009 | 214 | 0.080 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2010 | 168 | 0.080 |
Why?
|
Cryopreservation | 2 | 2022 | 631 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3350 | 0.080 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 1987 | 29 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 2 | 2017 | 153 | 0.080 |
Why?
|
Glucagon | 3 | 1981 | 529 | 0.080 |
Why?
|
Phenotype | 3 | 2021 | 16311 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2650 | 0.080 |
Why?
|
Thyrotropin | 1 | 2010 | 817 | 0.080 |
Why?
|
Oocytes | 2 | 2022 | 1217 | 0.080 |
Why?
|
Electrolytes | 1 | 2008 | 277 | 0.080 |
Why?
|
Animals, Newborn | 5 | 1986 | 2840 | 0.080 |
Why?
|
Life Style | 4 | 2020 | 3730 | 0.080 |
Why?
|
Bicarbonates | 1 | 2008 | 311 | 0.080 |
Why?
|
Hyperinsulinism | 1 | 2010 | 412 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 1998 | 3034 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1743 | 0.070 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1989 | 427 | 0.070 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 1986 | 41 | 0.070 |
Why?
|
Mutagenesis, Insertional | 1 | 2009 | 661 | 0.070 |
Why?
|
Animals | 27 | 2014 | 169420 | 0.070 |
Why?
|
C-Peptide | 2 | 2018 | 408 | 0.070 |
Why?
|
Testis | 1 | 1989 | 802 | 0.070 |
Why?
|
Preventive Medicine | 1 | 2008 | 262 | 0.070 |
Why?
|
Adult | 20 | 2023 | 212266 | 0.070 |
Why?
|
Sodium-Glucose Transporter 1 | 3 | 2005 | 114 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2330 | 0.070 |
Why?
|
Lipoproteins | 1 | 1991 | 914 | 0.070 |
Why?
|
Taxes | 1 | 2008 | 206 | 0.070 |
Why?
|
Cities | 1 | 2008 | 498 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1118 | 0.070 |
Why?
|
Blotting, Northern | 2 | 2005 | 1625 | 0.070 |
Why?
|
Ventricular Remodeling | 1 | 2013 | 1239 | 0.070 |
Why?
|
Weight Gain | 2 | 2008 | 2221 | 0.070 |
Why?
|
Iodine Radioisotopes | 1 | 2009 | 1028 | 0.070 |
Why?
|
Hypothyroidism | 1 | 2010 | 649 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2016 | 1738 | 0.070 |
Why?
|
Splanchnic Circulation | 1 | 1984 | 106 | 0.070 |
Why?
|
Thimerosal | 1 | 2004 | 17 | 0.070 |
Why?
|
Gastrectomy | 1 | 2009 | 548 | 0.070 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2004 | 27 | 0.070 |
Why?
|
Animals, Suckling | 1 | 2004 | 78 | 0.060 |
Why?
|
Base Sequence | 4 | 2009 | 13179 | 0.060 |
Why?
|
Sulfonylurea Compounds | 1 | 2005 | 191 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2015 | 72443 | 0.060 |
Why?
|
Carbamates | 1 | 2005 | 197 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2009 | 1695 | 0.060 |
Why?
|
School Health Services | 1 | 2008 | 380 | 0.060 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 6552 | 0.060 |
Why?
|
Early Growth Response Protein 1 | 1 | 2004 | 141 | 0.060 |
Why?
|
Caffeine | 1 | 1989 | 704 | 0.060 |
Why?
|
Exercise | 2 | 2020 | 5427 | 0.060 |
Why?
|
Body Weight | 8 | 2013 | 4688 | 0.060 |
Why?
|
Sequence Alignment | 3 | 2009 | 2284 | 0.060 |
Why?
|
Nutrition Policy | 1 | 2008 | 472 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7885 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11689 | 0.060 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 1043 | 0.060 |
Why?
|
Glucose Transporter Type 2 | 3 | 2005 | 65 | 0.060 |
Why?
|
Child Development | 1 | 2015 | 2199 | 0.060 |
Why?
|
Risk Factors | 6 | 2018 | 70866 | 0.060 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 2 | 2004 | 95 | 0.060 |
Why?
|
Exons | 1 | 2009 | 2466 | 0.060 |
Why?
|
Vagus Nerve | 1 | 2005 | 444 | 0.060 |
Why?
|
Molecular Sequence Data | 4 | 2009 | 18591 | 0.060 |
Why?
|
Drug Combinations | 2 | 2019 | 1928 | 0.060 |
Why?
|
Nutritional Status | 2 | 2009 | 1544 | 0.060 |
Why?
|
Papio | 5 | 1989 | 672 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2167 | 0.060 |
Why?
|
Vitrification | 1 | 2022 | 42 | 0.060 |
Why?
|
Parents | 2 | 2015 | 3178 | 0.050 |
Why?
|
Alanine | 2 | 1984 | 586 | 0.050 |
Why?
|
Binding Sites | 2 | 2004 | 6214 | 0.050 |
Why?
|
Gynecomastia | 1 | 1982 | 89 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 14161 | 0.050 |
Why?
|
Zinc Fingers | 1 | 2004 | 595 | 0.050 |
Why?
|
Duodenum | 1 | 2005 | 473 | 0.050 |
Why?
|
Cosmetics | 1 | 1982 | 86 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2328 | 0.050 |
Why?
|
Disclosure | 1 | 2008 | 742 | 0.050 |
Why?
|
Rats | 9 | 2008 | 24860 | 0.050 |
Why?
|
Exercise Therapy | 2 | 2019 | 894 | 0.050 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 1980 | 25 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 5 | 2005 | 8545 | 0.050 |
Why?
|
Receptors, Androgen | 1 | 1987 | 1049 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3428 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39300 | 0.050 |
Why?
|
Thiazoles | 2 | 2019 | 1515 | 0.050 |
Why?
|
Carboxylic Acids | 1 | 1980 | 103 | 0.050 |
Why?
|
Glucokinase | 1 | 2020 | 91 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2012 | 4296 | 0.050 |
Why?
|
Stress, Physiological | 3 | 2004 | 1426 | 0.050 |
Why?
|
Dexamethasone | 2 | 1994 | 1925 | 0.050 |
Why?
|
Myocardium | 1 | 2013 | 4909 | 0.050 |
Why?
|
Oxygen Consumption | 4 | 1989 | 1930 | 0.050 |
Why?
|
Hydatidiform Mole | 1 | 2002 | 276 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2014 | 4057 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1 | 1 | 1998 | 32 | 0.040 |
Why?
|
Prader-Willi Syndrome | 2 | 2010 | 69 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2019 | 148 | 0.040 |
Why?
|
Live Birth | 1 | 2022 | 463 | 0.040 |
Why?
|
Aging | 2 | 1994 | 8350 | 0.040 |
Why?
|
Administration, Oral | 2 | 2005 | 3956 | 0.040 |
Why?
|
Point Mutation | 1 | 2004 | 1651 | 0.040 |
Why?
|
Darkness | 1 | 1998 | 176 | 0.040 |
Why?
|
Brain Injuries | 1 | 2010 | 1907 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4352 | 0.040 |
Why?
|
Plasmids | 1 | 2004 | 2459 | 0.040 |
Why?
|
Mice | 5 | 2014 | 80375 | 0.040 |
Why?
|
Kidney | 3 | 1986 | 6881 | 0.040 |
Why?
|
Patient Compliance | 1 | 2009 | 2744 | 0.040 |
Why?
|
Kinetics | 3 | 2001 | 6655 | 0.040 |
Why?
|
Age Factors | 5 | 2013 | 18784 | 0.040 |
Why?
|
Consensus Sequence | 1 | 1998 | 379 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 2 | 1995 | 190 | 0.040 |
Why?
|
Laparoscopy | 1 | 2009 | 1980 | 0.040 |
Why?
|
Weight Loss | 1 | 2009 | 2515 | 0.040 |
Why?
|
Piperidines | 1 | 2005 | 1582 | 0.040 |
Why?
|
Ketone Bodies | 1 | 1977 | 77 | 0.040 |
Why?
|
Communicable Disease Control | 1 | 2004 | 811 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1998 | 1119 | 0.040 |
Why?
|
Hepatocytes | 1 | 2004 | 1238 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2018 | 415 | 0.040 |
Why?
|
HLA Antigens | 2 | 1981 | 1545 | 0.040 |
Why?
|
Diet Therapy | 1 | 2018 | 159 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2020 | 1581 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2004 | 800 | 0.040 |
Why?
|
Autoantibodies | 1 | 2005 | 2008 | 0.040 |
Why?
|
Androgens | 2 | 2018 | 1233 | 0.040 |
Why?
|
Cell Division | 1 | 2004 | 4699 | 0.040 |
Why?
|
Muscles | 1 | 1981 | 1556 | 0.040 |
Why?
|
Blotting, Western | 1 | 2004 | 5379 | 0.030 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2018 | 543 | 0.030 |
Why?
|
Autistic Disorder | 1 | 2004 | 1068 | 0.030 |
Why?
|
Transfection | 1 | 2004 | 6089 | 0.030 |
Why?
|
Virilism | 1 | 1994 | 29 | 0.030 |
Why?
|
Protein Binding | 2 | 2004 | 9559 | 0.030 |
Why?
|
Longevity | 1 | 2022 | 1030 | 0.030 |
Why?
|
3-O-Methylglucose | 1 | 1994 | 37 | 0.030 |
Why?
|
Methylglucosides | 1 | 1994 | 36 | 0.030 |
Why?
|
Hyperandrogenism | 1 | 1994 | 37 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2995 | 0.030 |
Why?
|
Counseling | 1 | 2022 | 1510 | 0.030 |
Why?
|
Radioisotope Dilution Technique | 1 | 1993 | 72 | 0.030 |
Why?
|
RNA | 1 | 2004 | 2613 | 0.030 |
Why?
|
Overweight | 2 | 2017 | 2272 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2021 | 19910 | 0.030 |
Why?
|
Adrenal Gland Diseases | 1 | 1994 | 133 | 0.030 |
Why?
|
Deoxyglucose | 1 | 1994 | 341 | 0.030 |
Why?
|
Fetal Blood | 2 | 1993 | 1324 | 0.030 |
Why?
|
Ovarian Diseases | 1 | 1994 | 137 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13643 | 0.030 |
Why?
|
Ventricular Function, Left | 2 | 2018 | 3364 | 0.030 |
Why?
|
Analysis of Variance | 2 | 1993 | 6501 | 0.030 |
Why?
|
Neurosecretory Systems | 1 | 1994 | 237 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1135 | 0.030 |
Why?
|
Bone Development | 2 | 2015 | 484 | 0.030 |
Why?
|
Radioimmunoassay | 4 | 1990 | 956 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2002 | 1482 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 14438 | 0.030 |
Why?
|
Regression Analysis | 2 | 1993 | 6495 | 0.030 |
Why?
|
Carbon Radioisotopes | 1 | 1993 | 612 | 0.030 |
Why?
|
Diabetes Complications | 2 | 2004 | 1397 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2004 | 2091 | 0.030 |
Why?
|
Eating | 2 | 2001 | 1454 | 0.030 |
Why?
|
Gene Frequency | 1 | 1979 | 3722 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2018 | 62004 | 0.030 |
Why?
|
Light | 1 | 1998 | 1434 | 0.030 |
Why?
|
Hepatocyte Nuclear Factors | 1 | 2010 | 1 | 0.030 |
Why?
|
Hypothalamic Diseases | 1 | 2012 | 140 | 0.030 |
Why?
|
Jejunum | 2 | 2005 | 502 | 0.030 |
Why?
|
Propylthiouracil | 1 | 1970 | 68 | 0.030 |
Why?
|
Arginine | 4 | 2004 | 953 | 0.030 |
Why?
|
Carbon Dioxide | 2 | 1989 | 1130 | 0.030 |
Why?
|
Adrenal Glands | 2 | 2012 | 546 | 0.020 |
Why?
|
Echocardiography | 3 | 2018 | 5044 | 0.020 |
Why?
|
Mutation | 3 | 2020 | 29291 | 0.020 |
Why?
|
Young Adult | 5 | 2019 | 56226 | 0.020 |
Why?
|
Ovarian Function Tests | 1 | 1989 | 12 | 0.020 |
Why?
|
Adiponectin | 1 | 2016 | 1089 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2677 | 0.020 |
Why?
|
Cardiac Output | 2 | 1984 | 905 | 0.020 |
Why?
|
Dwarfism, Pituitary | 1 | 2010 | 50 | 0.020 |
Why?
|
Time Factors | 4 | 2004 | 40875 | 0.020 |
Why?
|
Dealkylation | 1 | 1989 | 2 | 0.020 |
Why?
|
Apolipoproteins C | 1 | 2009 | 59 | 0.020 |
Why?
|
Fibrous Dysplasia, Polyostotic | 1 | 1989 | 36 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 7960 | 0.020 |
Why?
|
Ketosis | 1 | 1989 | 48 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2012 | 13217 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1757 | 0.020 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 1989 | 47 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 218 | 0.020 |
Why?
|
Apolipoprotein C-III | 1 | 2010 | 227 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9030 | 0.020 |
Why?
|
Bone and Bones | 1 | 1999 | 2568 | 0.020 |
Why?
|
Haplorhini | 3 | 1977 | 581 | 0.020 |
Why?
|
Amenorrhea | 1 | 2012 | 486 | 0.020 |
Why?
|
Somatomedins | 2 | 1980 | 196 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 1989 | 487 | 0.020 |
Why?
|
Breath Tests | 1 | 1989 | 286 | 0.020 |
Why?
|
Acidosis | 1 | 1989 | 272 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 1989 | 316 | 0.020 |
Why?
|
Apoptosis | 1 | 2004 | 9973 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2445 | 0.020 |
Why?
|
Prolactin | 1 | 1989 | 672 | 0.020 |
Why?
|
Lipoprotein(a) | 1 | 1991 | 394 | 0.020 |
Why?
|
Testosterone Congeners | 1 | 1987 | 59 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 942 | 0.020 |
Why?
|
Nutritional Requirements | 1 | 1988 | 286 | 0.020 |
Why?
|
COS Cells | 1 | 2008 | 1201 | 0.020 |
Why?
|
Vagotomy, Truncal | 1 | 2005 | 6 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2004 | 11655 | 0.020 |
Why?
|
Glucose Transporter Type 5 | 1 | 2005 | 14 | 0.020 |
Why?
|
Minerals | 1 | 1987 | 269 | 0.020 |
Why?
|
Sucrase | 1 | 2005 | 62 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 2682 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2018 | 3800 | 0.020 |
Why?
|
Secretory Rate | 2 | 1989 | 84 | 0.020 |
Why?
|
Vulvovaginitis | 1 | 1984 | 15 | 0.020 |
Why?
|
Risk Assessment | 1 | 2007 | 23464 | 0.020 |
Why?
|
Ligation | 1 | 1986 | 480 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2577 | 0.020 |
Why?
|
Ovary | 1 | 1989 | 1000 | 0.020 |
Why?
|
Placenta | 1 | 1993 | 1538 | 0.020 |
Why?
|
Clitoris | 1 | 1984 | 32 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10666 | 0.020 |
Why?
|
Cartilage | 2 | 1980 | 806 | 0.020 |
Why?
|
Potassium Deficiency | 1 | 2004 | 10 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1986 | 2259 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1939 | 0.020 |
Why?
|
Birth Weight | 1 | 2012 | 1941 | 0.020 |
Why?
|
Hydroxybutyrates | 2 | 1989 | 84 | 0.020 |
Why?
|
African Americans | 1 | 1979 | 5003 | 0.020 |
Why?
|
Transglutaminases | 1 | 2005 | 189 | 0.020 |
Why?
|
Hormones | 1 | 1987 | 853 | 0.020 |
Why?
|
Ammonia | 1 | 1984 | 238 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9596 | 0.020 |
Why?
|
Sex Characteristics | 2 | 2009 | 2550 | 0.020 |
Why?
|
Mathematics | 1 | 1984 | 745 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 2004 | 666 | 0.010 |
Why?
|
Thymidine | 2 | 1980 | 342 | 0.010 |
Why?
|
Societies, Medical | 1 | 2015 | 3754 | 0.010 |
Why?
|
Chorionic Gonadotropin | 2 | 2002 | 465 | 0.010 |
Why?
|
Extracellular Fluid | 1 | 2004 | 168 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5265 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 11201 | 0.010 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 1984 | 238 | 0.010 |
Why?
|
Antithyroid Agents | 1 | 2002 | 74 | 0.010 |
Why?
|
Urea | 1 | 1984 | 441 | 0.010 |
Why?
|
Phosphates | 2 | 2004 | 780 | 0.010 |
Why?
|
Uterus | 1 | 1986 | 677 | 0.010 |
Why?
|
Phlorhizin | 1 | 2001 | 39 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3713 | 0.010 |
Why?
|
Sodium Chloride | 1 | 2004 | 630 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 40029 | 0.010 |
Why?
|
Myocardial Contraction | 2 | 1987 | 1639 | 0.010 |
Why?
|
Guanosine | 1 | 2001 | 60 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2013 | 21797 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2010 | 4266 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1984 | 1558 | 0.010 |
Why?
|
Temperature | 1 | 1987 | 2145 | 0.010 |
Why?
|
Stroke Volume | 1 | 2013 | 4486 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4893 | 0.010 |
Why?
|
Diet Fads | 1 | 1980 | 12 | 0.010 |
Why?
|
Thorax | 1 | 2003 | 515 | 0.010 |
Why?
|
Electric Conductivity | 1 | 2001 | 426 | 0.010 |
Why?
|
Catheterization | 1 | 1986 | 1448 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3516 | 0.010 |
Why?
|
Methyltestosterone | 1 | 1979 | 19 | 0.010 |
Why?
|
|